Key statistics
On Monday, Fractyl Health Inc (GUTS:NMQ) closed at 2.27, 30.46% above the 52 week low of 1.74 set on Aug 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.12 |
---|---|
High | 2.31 |
Low | 2.11 |
Bid | 2.22 |
Offer | 2.50 |
Previous close | 2.09 |
Average volume | 369.31k |
---|---|
Shares outstanding | 48.10m |
Free float | 45.77m |
P/E (TTM) | -- |
Market cap | 100.53m USD |
EPS (TTM) | -1.43 USD |
Data delayed at least 15 minutes, as of Nov 25 2024 21:00 GMT.
More ▼
- Fractyl Health to Participate in the Upcoming December Conferences
- Fractyl Health Reports Third Quarter 2024 Financial Results and Provides Business Updates
- Fractyl Health to Present New Preclinical Data on Sustained Weight Maintenance and Blood Sugar from its Rejuva® RJVA-001 Single-Administration GLP-1 Pancreatic Gene Therapy Candidate at ObesityWeek® 2024
- Fractyl Health Presented New Analysis from Pooled Data of Revita® Clinical Studies Demonstrating Durable Weight Loss Maintenance for One Year at ObesityWeek® 2024
- Fractyl Health to Report Third Quarter 2024 Financial Results and Provide Business Updates on November 12, 2024
- Fractyl Health to Present Compelling Weight Maintenance Data from both Revita® and Rejuva® Platforms at ObesityWeek® 2024
- Fractyl Health to Present at Chardan’s 8th Annual Genetic Medicines Conference
- Fractyl Health to Participate in Upcoming September Investor Conferences
- Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business Updates
- Fractyl Health Announces Clinical Results from German Real-World Registry Showing Meaningful and Sustained Weight Loss for at Least One Year After a Single Revita® Endoscopic Procedure
More ▼